Cargando…
PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression
Breast cancer progression, treatment resistance, and relapse are thought to originate from a small population of tumor cells, breast cancer stem cells (BCSCs). Identification of factors critical for BCSC function is therefore vital for the development of therapies. Here, we identify the arginine met...
Autores principales: | Chiang, Kelly, Zielinska, Agnieszka E., Shaaban, Abeer M., Sanchez-Bailon, Maria Pilar, Jarrold, James, Clarke, Thomas L., Zhang, Jingxian, Francis, Adele, Jones, Louise J., Smith, Sally, Barbash, Olena, Guccione, Ernesto, Farnie, Gillian, Smalley, Matthew J., Davies, Clare C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746596/ https://www.ncbi.nlm.nih.gov/pubmed/29262329 http://dx.doi.org/10.1016/j.celrep.2017.11.096 |
Ejemplares similares
-
PRMT5-mediated regulation of developmental myelination
por: Scaglione, Antonella, et al.
Publicado: (2018) -
PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination
por: Clarke, Thomas L., et al.
Publicado: (2017) -
Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer
por: Almeida-Rios, Diogo, et al.
Publicado: (2016) -
Linking PRMT5 to breast cancer stem cells: New therapeutic opportunities?
por: Chiang, Kelly, et al.
Publicado: (2018) -
Analysis of Myc-Induced Histone Modifications on Target Chromatin
por: Martinato, Francesca, et al.
Publicado: (2008)